South Africa's biggest pharmaceutical producer Aspen Pharmacare said on Friday it had reached a 25 million euro ($29.2 ...

A senior biosecurity adviser at the U.S. Department of Health and Human Services, who has made several critical statements ...

Steven J. Hatfill has been ousted from his role at the federal health agency charged with preparing for disasters such as ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

Recently, Zacks.com users have been paying close attention to Moderna (MRNA). This makes it worthwhile to examine what the stock has in store.

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for ...

The Covid-19 shot may have further-reaching benefits than previously thought, as mRNA vaccines appear to help increase the ...

The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to ...

The Covid-19 mRNA-based vaccines that saved 2.5 million lives globally in the pandemic could help spark the immune system to ...

Moderna’s market value has fallen by more than 90% — $185 billion, or a full Sony — from its 2021 peak to around $10 billion ...